Literature DB >> 11555722

Endometrial cancer: is surgical staging necessary?

J W Orr1, P Y Roland, D Leichter, P F Orr.   

Abstract

Surgical staging has become the standard of care for the treatment of women with endometrial cancer. Recent scientific publications have confirmed the relative safety of this procedure when performed by subspecialty trained surgeons and have provided compelling evidence that the routine use of postoperative teletherapy is not cost effective, nor does it offer improved survival. New questions as to the safety and effectiveness of a laparoscopic staging approach have been answered in the affirmative. Although the extent of staging has not yet been defined, growing evidence suggests that preoperative studies and intraoperative clinical opinion cannot be consistently counted on to be predictive of postoperative histologic status. Therefore, all patients should be considered at risk and should undergo an operation in a clinical situation that offers the immediate availability of retroperitoneal staging or cytoreductive surgery if necessary.

Entities:  

Mesh:

Year:  2001        PMID: 11555722     DOI: 10.1097/00001622-200109000-00017

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  4 in total

1.  Comparison of preoperative endometrial biopsy grade and final pathologic diagnosis in patients with endometrioid endometrial cancer.

Authors:  Behiye Pınar Çilesiz Göksedef; Ozgür Akbayır; Aytül Corbacıoğlu; Hakan Güraslan; Fatmagül Sencan; Onur Erol; Ahmet Cetin
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-06-01

2.  Changing Practice of Gynecologic Oncology based on Current Evidence.

Authors:  Hemant B Tongaonkar
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Sentinel lymph node biopsy in endometrial cancer: description of the technique and preliminary results.

Authors:  Oğuzhan Kuru; Samet Topuz; Serhat Sen; Cem Iyibozkurt; Sinan Berkman
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

4.  Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer.

Authors:  Misaki Fue; Yasuhiro Miki; Kiyoshi Takagi; Chiaki Hashimoto; Nobuo Yaegashi; Takashi Suzuki; Kiyoshi Ito
Journal:  Int J Mol Sci       Date:  2018-08-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.